Vopratelimab Uses, Dosage, Side Effects and more
Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Vopratelimab |
| Generic | Vopratelimab |
| Vopratelimab Other Names | Vopratelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
